Cormorant Asset Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,188,659
| Closed | -$2.74M | – | 67 |
|
|
2023
Q2 | $2.74M | Hold |
9,188,659
| – | – | 0.15% | 54 |
|
|
2023
Q1 | $3.97M | Hold |
9,188,659
| – | – | 0.26% | 51 |
|
|
2022
Q4 | $10.8M | Sell |
9,188,659
-1,072,901
| -10% | -$1.27M | 0.73% | 36 |
|
|
2022
Q3 | $23.8M | Buy |
10,261,560
+3,301,020
| +47% | +$7.66M | 1.66% | 22 |
|
|
2022
Q2 | $15.2M | Buy |
6,960,540
+250,000
| +4% | +$547K | 1.15% | 29 |
|
|
2022
Q1 | $62M | Buy |
+6,710,540
| New | +$62M | 4.76% | 5 |
|